Article Versions Notes

Ordóñez-Reyes C, Garcia-Robledo JE, Chamorro DF, Mosquera A, Sussmann L, Ruiz-Patiño A, Arrieta O, Zatarain-Barrón L, Rojas L, Russo A, et al. Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics. 2022; 14(6):1243. https://doi.org/10.3390/pharmaceutics14061243

Ordóñez-Reyes, Camila, Juan Esteban Garcia-Robledo, Diego F. Chamorro, Andrés Mosquera, Liliana Sussmann, Alejandro Ruiz-Patiño, Oscar Arrieta, Lucia Zatarain-Barrón, Leonardo Rojas, Alessandro Russo, and et al. 2022. "Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question" Pharmaceutics 14, no. 6: 1243. https://doi.org/10.3390/pharmaceutics14061243

Ordóñez-Reyes, C., Garcia-Robledo, J. E., Chamorro, D. F., Mosquera, A., Sussmann, L., Ruiz-Patiño, A., Arrieta, O., Zatarain-Barrón, L., Rojas, L., Russo, A., de Miguel-Perez, D., Rolfo, C., & Cardona, A. F. (2022). Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics, 14(6), 1243. https://doi.org/10.3390/pharmaceutics14061243